TR200002848T2 - Ksantan zamkı içeren, jelleşen oftalmik bileşimler. - Google Patents

Ksantan zamkı içeren, jelleşen oftalmik bileşimler.

Info

Publication number
TR200002848T2
TR200002848T2 TR2000/02848T TR200002848T TR200002848T2 TR 200002848 T2 TR200002848 T2 TR 200002848T2 TR 2000/02848 T TR2000/02848 T TR 2000/02848T TR 200002848 T TR200002848 T TR 200002848T TR 200002848 T2 TR200002848 T2 TR 200002848T2
Authority
TR
Turkey
Prior art keywords
xanthan gum
compositions containing
ophthalmic compositions
containing xanthan
gel ophthalmic
Prior art date
Application number
TR2000/02848T
Other languages
English (en)
Inventor
Bawa Rajan
E.Hall Rex
P. Kabra Bhagwati
E.Teague James
Original Assignee
Alcon Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories, Inc. filed Critical Alcon Laboratories, Inc.
Publication of TR200002848T2 publication Critical patent/TR200002848T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Bir sivi halinde uygulanabilen ve gözle temas ettiginde jellesen oftalmik ilaç verici vasitalar açiklanmistir. Vasitalar, ksantan zamki içerirler.
TR2000/02848T 1998-04-07 1999-03-26 Ksantan zamkı içeren, jelleşen oftalmik bileşimler. TR200002848T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8100498P 1998-04-07 1998-04-07

Publications (1)

Publication Number Publication Date
TR200002848T2 true TR200002848T2 (tr) 2001-02-21

Family

ID=22161189

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02848T TR200002848T2 (tr) 1998-04-07 1999-03-26 Ksantan zamkı içeren, jelleşen oftalmik bileşimler.

Country Status (18)

Country Link
EP (1) EP1069913B1 (tr)
JP (1) JP4545927B2 (tr)
KR (1) KR100598722B1 (tr)
CN (1) CN1133466C (tr)
AR (1) AR016460A1 (tr)
AT (1) ATE245451T1 (tr)
AU (1) AU740586B2 (tr)
BR (1) BR9910113A (tr)
CA (1) CA2322579C (tr)
DE (1) DE69909768T2 (tr)
DK (1) DK1069913T3 (tr)
ES (1) ES2203103T3 (tr)
NZ (1) NZ506921A (tr)
PT (1) PT1069913E (tr)
TR (1) TR200002848T2 (tr)
TW (1) TWI262797B (tr)
WO (1) WO1999051273A1 (tr)
ZA (1) ZA200004413B (tr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
WO2000042986A2 (de) * 1999-01-19 2000-07-27 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Künstliche tränenflüssigkeit in gelform
JP2003513046A (ja) * 1999-11-01 2003-04-08 アルコン，インコーポレイテッド フルオロキノロン抗生薬およびキサンタンガムを含有する薬学的組成物
ATE291913T1 (de) * 2000-01-25 2005-04-15 Alcon Inc Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
AU4114301A (en) * 2000-03-16 2001-09-24 Sucampo Ag Treatment of ocular hypertension and glaucoma
US6458836B1 (en) 2000-03-16 2002-10-01 Sucampo, A.G. Treatment of ocular hypertension and glaucoma
JP4927298B2 (ja) 2000-07-14 2012-05-09 アラーガン、インコーポレイテッド α−２−アドレナリンアゴニスト成分を含有する組成物
AU2001273268B2 (en) 2000-07-14 2005-08-25 Allergan, Inc. Compositions containing therapeutically active components having enhanced solubility
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension
AU2001270593A1 (en) * 2000-07-28 2002-02-13 Alcon Universal Ltd. Pharmaceutical compositions containing tobramycin and xanthan gum
WO2002040030A1 (en) * 2000-11-16 2002-05-23 Alcon Manufacturing, Ltd. Combination therapy for lowering and controlling intraocular pressure
AU2002232437A1 (en) 2000-12-20 2002-07-01 Alcon Universal Ltd. Ophthalmic lubricating solution adapted for use in lasik surgery
WO2002049610A2 (en) 2000-12-20 2002-06-27 Alcon, Inc. Ophthalmic irrigating solution adapted for use in lasik surgery
JP4169596B2 (ja) 2000-12-20 2008-10-22 アルコン、インコーポレイテッド 白内障を液化破壊により取り除くための溶液
US7084130B2 (en) 2001-12-11 2006-08-01 Alcon, Inc. Intraocular irrigating solution having improved flow characteristics
AU2003215820A1 (en) * 2002-03-28 2003-10-13 Sucampo Ag Method for treating ocular hypertension and glaucoma
US7030149B2 (en) * 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
ES2304913T3 (es) * 2002-04-30 2012-03-01 Sifi S.P.A. Composiciones farmacéuticas reepitelializantes que contienen goma de xantano.
US8580851B2 (en) 2002-08-21 2013-11-12 Sucampo Ag Ophthalmic solution
KR20120005052A (ko) * 2003-08-21 2012-01-13 수캄포 아게 안과용 조성물
WO2006035969A1 (ja) * 2004-09-28 2006-04-06 Senju Pharmaceutical Co., Ltd. キサンタンガムおよびアミノ酸を含有する眼科用組成物
WO2007032997A1 (en) * 2005-09-13 2007-03-22 Bausch & Lomb Incorporated Ophthalmic formulation containing loteprednol etabonate for treatment of dry eye
WO2007108541A1 (ja) 2006-03-23 2007-09-27 Senju Pharmaceutical Co., Ltd. キサンタンガムおよびブドウ糖を含有する眼科用組成物
MX2009001037A (es) 2006-07-31 2009-05-15 Senju Pharma Co Preparacion liquida acuosa que contiene compuesto de amida.
JP5245078B2 (ja) * 2006-10-12 2013-07-24 杏林製薬株式会社 ガチフロキサシンの眼内移行性を向上させた水性液剤
TWI544934B (zh) 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
EP2566453A4 (en) * 2010-05-07 2014-05-07 Sun Pharma Advanced Res Co Ltd NOVEL OPHTHALMIC COMPOSITIONS
JP5713791B2 (ja) * 2010-05-12 2015-05-07 テイカ製薬株式会社 眼科用剤
EP2585037A1 (en) * 2010-06-23 2013-05-01 Alcon Research, Ltd. Topical ophthalmic suspensions containing tobramycin and dexamethasone
JP5870459B2 (ja) * 2010-08-27 2016-03-01 わかもと製薬株式会社 点眼用水性組成物
WO2016061145A1 (en) 2014-10-13 2016-04-21 Symic Biomedical, Inc. Synthetic proteoglycans for preventing tissue adhesion
US20170368192A1 (en) 2014-10-13 2017-12-28 Symic Ip, Llc Luminal vessel coating for arteriovenous fistula
WO2016065083A1 (en) 2014-10-21 2016-04-28 Symic Biomedical, Inc. Peptidoglycans comprising collagen-binding peptides for treating gastroesophageal injury
CN104825386A (zh) * 2015-05-25 2015-08-12 湖北汇瑞药业股份有限公司 一种表皮麻醉凝胶及其制备方法
US20170112941A1 (en) 2015-10-13 2017-04-27 Symic Ip, Llc Ve-cadherin binding bioconjugate
KR101770324B1 (ko) * 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
CN109722347B (zh) * 2019-01-03 2020-12-29 山东省药学科学院 一种含有黄原胶的保湿润滑组合物及其应用
KR102678138B1 (ko) * 2022-09-29 2024-06-25 주식회사태준제약 브리모니딘을 포함하는 안과용 조성물
WO2025137749A1 (pt) * 2023-12-27 2025-07-03 Eurofarma Laboratórios S.A. Processo de solubilização de olopatadina e seu uso
CN119318630B (zh) * 2024-10-16 2025-08-22 苏州欧康维视生物科技有限公司 一种阿托品药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4814160A (en) * 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
EP0859603B1 (en) * 1996-07-08 2008-12-17 Penwest Pharmaceuticals Co. Sustained release matrix for high-dose insoluble drugs

Also Published As

Publication number Publication date
ZA200004413B (en) 2001-05-22
WO1999051273A1 (en) 1999-10-14
JP4545927B2 (ja) 2010-09-15
DE69909768T2 (de) 2004-06-17
DE69909768D1 (de) 2003-08-28
HK1031335A1 (en) 2001-06-15
BR9910113A (pt) 2000-12-26
EP1069913B1 (en) 2003-07-23
KR20010041473A (ko) 2001-05-25
KR100598722B1 (ko) 2006-07-11
EP1069913A1 (en) 2001-01-24
ES2203103T3 (es) 2004-04-01
NZ506921A (en) 2002-02-01
CA2322579A1 (en) 1999-10-14
ATE245451T1 (de) 2003-08-15
AU740586B2 (en) 2001-11-08
CA2322579C (en) 2001-08-28
AU3194799A (en) 1999-10-25
CN1295483A (zh) 2001-05-16
TWI262797B (en) 2006-10-01
JP2002510654A (ja) 2002-04-09
AR016460A1 (es) 2001-07-04
CN1133466C (zh) 2004-01-07
DK1069913T3 (da) 2003-11-17
PT1069913E (pt) 2003-11-28

Similar Documents

Publication Publication Date Title
DK0725628T3 (da) Termisk geldannende lægemiddelindgivelsesvehikler indeholdende celluloseethere
TWI262797B (en) Gelling ophthalmic compositions containing xanthan gum
CA2329761A1 (fr) Feuille de papier absorbant gaufre
DE3877618D1 (de) Mittel, bestehend aus einer organischen verbindung des siliciums, kombiniert mit einer kosmetisch aktiven substanz.
ATE215899T1 (de) Behälter für kontaktlinsen
MX170239B (es) Aplicador topico para liquido
BR0315583A (pt) Cobertura semi-hidrofóbica para um produto absorvente
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
AU6004798A (en) Electrochromic system
TR200200737T2 (tr) Siproflaksasin ve deksametazon içeren lokal süspansiyon formülasyonları
AU2413184A (en) Vapor-dispensing device
ES2015508T3 (es) Dispositivo para fijar un contador de agua sobre la base de un soporte y procedimiento correspondiente.
MXPA05012319A (es) Suministro de compuestos con celulas sanguineas rehidratadas.
ATE144701T1 (de) Verwendung einer kombination aus gelbindender polysacchariden und fein verteilten arzneimittelträgern in ophtalmischen topischen zusammensetzungen
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
WO2004086039A8 (en) A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof
ES2171555T3 (es) Formulacion farmaceutica que incluye una hormona de crecimiento y de valina.
AU7383191A (en) Novel retinoids
BR0314787A (pt) Forma de dosagem de liberação modificada
DE60323520D1 (de) Dreischichtige tränenformulierung
TR200003357T2 (tr) Efervesan preparatlar.
GB1372713A (en) Devices for maintaining spectacles in position
CO5070588A1 (es) Comprimidos de ciclofosfamida recubiertos con pelicula
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
MX9303288A (es) Dispositivo contenedor para lentes de contacto.